These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12869294

  • 21. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
    Hanley DA, Zhang Q, Meilleur MC, Mavros P, Sen SS.
    Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
    [Abstract] [Full Text] [Related]

  • 22. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
    Bonnick S, Broy S, Kaiser F, Teutsch C, Rosenberg E, DeLucca P, Melton M.
    Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
    [Abstract] [Full Text] [Related]

  • 23. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE.
    Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460
    [Abstract] [Full Text] [Related]

  • 24. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.
    Griffiths F, Convery B.
    Br J Gen Pract; 1995 Jul 20; 45(396):355-8. PubMed ID: 7612339
    [Abstract] [Full Text] [Related]

  • 25. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.
    Suzuki Y, Whiting SJ, Davison KS, Chilibeck PD.
    J Nutr Health Aging; 2003 Jul 20; 7(5):296-9. PubMed ID: 12917743
    [Abstract] [Full Text] [Related]

  • 26. Survey of osteoporosis preventive care in community family medicine settings.
    Gourlay ML, Preisser JS, Callahan LF, Linville JC, Sloane PD.
    Fam Med; 2006 Jul 20; 38(10):724-30. PubMed ID: 17075746
    [Abstract] [Full Text] [Related]

  • 27. Compliance with drug therapies for the treatment and prevention of osteoporosis.
    McCombs JS, Thiebaud P, McLaughlin-Miley C, Shi J.
    Maturitas; 2004 Jul 15; 48(3):271-87. PubMed ID: 15207894
    [Abstract] [Full Text] [Related]

  • 28. Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.
    McClung MR, Siris E, Cummings S, Bolognese M, Ettinger M, Moffett A, Emkey R, Day W, Somayaji V, Lee A.
    Menopause; 2006 Jul 15; 13(3):377-86. PubMed ID: 16735934
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG, Kruse HP, Möhrke W, Oestreich A, Huppertz E.
    Int J Clin Pharmacol Res; 2004 Jul 15; 24(1):1-10. PubMed ID: 15575171
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Lipid profile and bone paradox: higher serum lipids are associated with higher bone mineral density in postmenopausal women.
    Brownbill RA, Ilich JZ.
    J Womens Health (Larchmt); 2006 Apr 15; 15(3):261-70. PubMed ID: 16620185
    [Abstract] [Full Text] [Related]

  • 34. Knowledge of osteoporosis correlated with hormone therapy use and health status.
    Vytrisalova M, Kubena A, Vlcek J, Palicka V, Hala T, Pavelka K.
    Maturitas; 2007 Jan 20; 56(1):21-9. PubMed ID: 16797149
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A longitudinal study of estrogen and calcium supplement use among Japanese women living in Hawaii.
    Davis JW, Ross PD, Wasnich RD.
    Prev Med; 1995 Mar 20; 24(2):159-65. PubMed ID: 7597018
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up.
    Prelevic GM, Markou A, Arnold A, Bartram C, Puzigaca Z, Ginsburg J.
    Maturitas; 2004 Mar 15; 47(3):229-34. PubMed ID: 15036493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.